Statistics for Vismodegib for Treatment of Periocular Basal Cell Carcinoma – 6-Year Experience from a Tertiary Cancer Center
Total visits
| views | |
|---|---|
| Vismodegib for Treatment of Periocular Basal Cell Carcinoma – 6-Year Experience from a Tertiary Cancer Center | 47 |
Total visits per month
| views | |
|---|---|
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
File Visits
| views | |
|---|---|
| An Bras Dermatol 2021_712.pdf | 38 |
Top country views
| views | |
|---|---|
| United States | 21 |
| China | 10 |
| Australia | 5 |
| Latvia | 3 |
| Canada | 2 |
| Ukraine | 2 |
| Argentina | 1 |
| India | 1 |
| Portugal | 1 |